General Information of Drug (ID:
DR1629) |
Drug Name |
AK-602
|
Synonyms |
Trastuzumab emtansine; GW-873140; SCHEMBL20530710 |
Indication |
Human immunodeficiency virus infection
[ICD11: 1C60]
|
Phase 3
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
483.5 |
Topological Polar Surface Area |
121 |
Heavy Atom Count |
36 |
Rotatable Bond Count |
5 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
9 |
Cross-matching ID |
- PubChem CID
- 135353969
- TTD Drug ID
- D0UG0K
- Formula
- C25H21N7O4
- Canonical SMILES
- CC1=CC(=NO1)C2=NN=C3N2N=C(C4=CC=CC=C43)OCC5=NC=C(C=C5)C(=O)N6CC7CC6CO7
- InChI
- 1S/C25H21N7O4/c1-14-8-21(30-36-14)23-28-27-22-19-4-2-3-5-20(19)24(29-32(22)23)35-12-16-7-6-15(10-26-16)25(33)31-11-18-9-17(31)13-34-18/h2-8,10,17-18H,9,11-13H2,1H3
- InChIKey
- WISMPDBQEVMXPG-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.